SYNERGI24-TMAO
About this project
Project information
SYNERGY24-TMAO is a five-year Synergy research project, funded by the Knowledge Foundation (KK-stiftelsen) and hosted at Örebro University, that aims to elucidate how the dietary metabolite Trimethylamine N-oxide (TMAO) acts as a shared driver of disease mechanisms across three highly prevalent chronic inflammatory diseases: cardiovascular disease (CVD), chronic kidney disease (CKD), and periodontitis.